【ChiCTR2000034585】World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
ChiCTR2000034585
正在进行
/
/
/
2020-07-11
/
/
疑似自閉症譜系障礙和發育遲緩
World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
This study aimed to examine the effectiveness of the adapted WHO-CST intervention in the local settings. The specific objectives of the study are: 1) to examine the effectiveness of WHO-CST programme in Hong Kong context; 2) to examine potential factors influencing the effectiveness of WHO-CST programme in Hong Kong context
随机平行对照
其它
The research team will randomly assign participants into 12 groups, as well as condition.
/
Charities Trust
/
60
/
2020-09-01
2021-07-31
/
The caregiver-child dyads will be recruited if they fulfilled the following inclusion criteria: For caregivers, they should be; 1. At least 18 years or above; 2. the primary caregiver who is responsible for the role of parenting the child, this could be biological parent (father or mother), guardian or other adult family member (i.e., the same caregiver who will attend the WHO-CST programme if s/he agrees); 3. living together with the target child; 4. able to communicate in Cantonese; 5. able to read and write basic Chinese; 6. planned to stay in Hong Kong for at least six months for most of the time for home visits and 9 sections of face-to-face group intervention and accessible by phone; Additionally, to ensure the adherence of WHO-CST programme, these caregivers shall allow the following procedures to be carried out during the programme implementation: 1. allow three home visits by facilitators who deliver the programme (World Health Organization, 2016). These MTs would be the professionals or para-professionals from HKU, governmental bodies and/or NGOs, and 2. agree to take videos for research purposes. The video-recording will take place on three home visits and 9 sections of face-to-face group intervention. For children, they should be: 1. between 2 and 6 years old; 2. screened positive on Chinese version of the Checklist for Autism in Toddlers (C-CHAT-23) Wong et al. (2004) or 3. suspected to display symptoms or behaviours of autism spectrum disorder, such as persistent deficits in social communication and social interaction across multiple contexts and restricted, repetitive patterns of behaviours, interest, or activities; 4. suspected to display symptoms or behaviours of communication disorder, such as persistent difficulties in the acquisition and use of language across modalities and language abilities are substantially and quantifiably below those expected age; 5. the above symptoms or behaviours are the primary concerns of developmental issues the child face as reported by caregivers or clinicians (children who are suspected to co-morbid other conditions, such as intellectual disability, attention deficit hyperactivity disorder, specific learning disorder, motor disorder are also eligible if these other conditions are not primary concerns of developmental issues).;
请登录查看Caregivers will be excluded if they fulfil the following criterion: Physical or mental condition that required hospitalization or frequent outpatient visits (e.g., three visits for 6 months). Children will be excluded if they fulfil one of the following criteria; 1. Deafness or blindness in the child; 2. Co-morbid physical and mental conditions that the child is now hospitalized; 3. Co-morbid motor skill developmental delays, physical disabilities or motor disorders, including stereotypic movement disorder, tic disorder, and other.;
请登录查看Hong Kong Jockey Club Charities Trust
/
Hong Kong Jockey Club Charities Trust的其他临床试验
- Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
- Effectiveness of post hospital discharge support program to improve the well-being of people with dementia and family caregivers
- Unpacking the concept of physical literacy to support children's physical literacy journey: a parent-focused intervention
- World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
- Community eHealth Care Project
- Effectiveness of a dementia friendly program and bluetooth tracking technology to enhance public knowledge and attitude on dementia and reduce caregiver anxiety on getting lost
香港大學社會科學學院的其他临床试验
- “厨厨有爱”:新来港人士社区融合计划
- Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
- World Health Organization Caregiver Skills Training (WHO-CST) Programme for Hong Kong Chinese families of young children with developmental delays or Autism Spectrum Disorders– Phase Three: evaluation of the pilot implementation
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

